Cerita populer
-
2 tahun lalu
ESMO 2023: Application of Novel Machine Learning Model in 68Ga-PSMA-11 PET/CT – Predicting Survival in Oligometastatic Prostate Cancer Patients
urotoday.com
-
2 tahun lalu
Stocks in play: Oncolytics Biotech Inc
ca.sports.yahoo.com
-
2 tahun lalu
Oncolytics Biotech Inc
baystreet.ca
-
2 tahun lalu
Oncolytics Biotech Presents Positive Updated Pancreatic Cancer Data From GOBLET Phase 1/2 Study At ESMO
infomeddnews.com
-
2 tahun lalu
Oncolytics Biotech® Inc.: Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
finanznachrichten.de
-
2 tahun lalu
ESMO 2023: External Validation of a Digital Pathology-Based Multimodal Artificial Intelligence (MMAI)-Derived Model in High-Risk M0/M1 Prostate Cancer Starting ADT in the Docetaxel or Abiraterone Phase 3 STAMPEDE Trials
urotoday.com
-
2 tahun lalu
ESMO 2023: A Novel Machine Learning Based Method to Detect Homozygous Deletion of Homologous Recombination Repair (HRR) Genes in Prostate Cancer
urotoday.com
-
2 tahun lalu
Spain's PLD Space expects first orbital launch in Q1 2026 from French Guiana
thestar.com.my
-
2 tahun lalu
Spain's PLD Space expects first orbital launch in Q1 2026 from French Guiana
theprint.in